Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

Cited by (1,000)

Items 501–600 of 1,000

1. Membralin deficiency dysregulates astrocytic glutamate homeostasis, leading to ALS-like impairment
   Lu-Lin Jiang, Bing Zhu, Yingjun Zhao, Xiaoguang Li, Tong‐Fei Liu, Juan Piña-Crespo, Lisa Zhou, Wenxi Xu, Maria José Gómez-Rodríguez, Haiyang Yu et al. · 2019 · Journal of Clinical Investigation
2. Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome
   Lee J. Martin, Margaret Wong · 2020 · Frontiers in Neurology
3. The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model
   Yansu Guo, Yuesheng Zhang, Di Wen, Weisong Duan, Ting An, Pengxiao Shi, Jingjing Wang, Zhongyao Li, Xiaoyu Chen, Chunyan Li · 2013 · Laboratory Investigation
4. Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis
   Maize C. Cao, Erin E. Cawston, Grace L. Chen, Collin Brooks, Jeroen E. Douwes, Dave McLean, E. Scott Graham, Mike Dragunow, Emma L. Scotter · 2022 · BMC Neurology
5. Intercellular mitochondrial transfer in the brain, a new perspective for targeted treatment of central nervous system diseases
   Ziang Geng, Shu Guan, Siqi Wang, Zhongxue Yu, Tiancong Liu, Shaonan Du, Chen Zhu · 2023 · CNS Neuroscience & Therapeutics
6. Superoxide dismutase‐1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice
   Daniel Bergemalm, Karin Forsberg, Vaibhav Srivastava, Karin S. Graffmo, Peter Munch Andersen, Thomas Brännström, Gunnar Wingsle, Stefan L. Marklund · 2010 · Journal of Neurochemistry
7. Altered astrocytic expression of TDP-43 does not influence motor neuron survival
   Amanda M. Haidet-Phillips, Sarah K. Gross, Timothy L. Williams, Alisha Tuteja, Alex Sherman, Myungsung Ko, Yun Ha Jeong, Philip C. Wong, Nicholas John Maragakis · 2013 · Experimental Neurology
8. Viral Delivery of Antioxidant Genes as a Therapeutic Strategy in Experimental Models of Amyotrophic Lateral Sclerosis
   Aikaterini Nanou, Adrian Higginbottom, Chiara F. Valori, Matthew Wyles, Ke Ning, Pamela J. Shaw, Mimoun Azzouz · 2013 · Molecular Therapy
9. Crosstalk between astrocytes and motor neurons: What is the message?
   Ludo Van Den Bosch, Wim Robberecht · 2008 · Experimental Neurology
10. Functional Multipotency of Stem Cells: A Conceptual Review of Neurotrophic Factor-Based Evidence and Its Role in Translational Research
    Dae Yul Yang, Dou Yu, Dou Dou, Ropper, Alexander E, Li, Jianxue, Serdar Kabataş, Serdar, Wakeman et al. · 2011 · Current Neuropharmacology
11. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1
    Eiichi Tokuda, Eriko Okawa, S. Watanabe, S.-i. Ono · 2013 · Human Molecular Genetics
12. Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases
    Jessica Lenzi, Francesca Pagani, Riccardo De Santis, Cristina Limatola, Irene Bozzoni, Silvia Di Angelantonio, Alessandro Rosa · 2016 · Stem Cell Research
13. Implications of white matter damage in amyotrophic lateral sclerosis
    Ting Zhou, Tina Khorshid Ahmad, Kiana Gozda, Jessica L. Truong, Jiming Kong, Michael Namaka · 2017 · Molecular Medicine Reports
14. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue
    Antonio Vallarola, Francesca M. Sironi, Massimo Tortarolo, Noemi Gatto, Roberta De Gioia, Laura Pasetto, Massimiliano De Paola, Alessandro Mariani, Supurna Ghosh, Richard L. Watson et al. · 2018 · Journal of Neuroinflammation
15. Impaired Mitophagy in Neurons and Glial Cells during Aging and Age-Related Disorders
    Vladimir S. Sukhorukov, Д. Н. Воронков, Tatiana I. Baranich, Natalia M. Mudzhiri, Alina Magnaeva, Sergey Nikolaevich Illarioshkin · 2021 · International Journal of Molecular Sciences
16. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis
    Petra Bergström, Malin von Otter, Staffan Nilsson, Ann-Charloth Nilsson, Michael Nilsson, Peter Munch Andersen, Ola Hammarsten, Henrik Zetterberg · 2013 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
17. Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse
    Wendy W. Yang, Richard L. Sidman, Tatyana V. Taksir, Christopher M. Treleaven, Jonathan A. Fidler, Seng H. Cheng, James C. Dodge, Lamya S. Shihabuddin · 2010 · Experimental Neurology
18. Astrocytic Vesicle Mobility in Health and Disease
    Maja Potokar, Nina Vardjan, Matjaž Stenovec, Mateja Gabrijel, Saša Trkov, Jernej Jorgačevski, Marko Kreft, Robert Zorec · 2013 · International Journal of Molecular Sciences
19. STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation
    Sidharth V. Puram, Cecil Yeung, Arezu Jahani‐Asl, Carrie Lin, Núria de la Iglesia, Geneviève Konopka, Laurie Jackson‐Grusby, Azad Bonni · 2012 · Journal of Neuroscience
20. Reverse‐engineering human regulatory networks
    Céline Lefèbvre, Gabrielle E. Rieckhof, Andrea Califano · 2012 · WIREs Systems Biology and Medicine
21. Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model
    Carolin Dahlke, Darius Saberi, Bastian Ott, Beate Brand‐Saberi, Thomas Schmitt‐John, Carsten Theiß · 2015 · Journal of Neuroinflammation
22. Human Stem Cell-Derived Astrocytes: Specification and Relevance for Neurological Disorders
    Giulia E. Tyzack, András Lakatos, Rickie Patani · 2016 · Current Stem Cell Reports
23. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS)
    Amanda M. Haidet-Phillips, Nicholas John Maragakis · 2015 · Brain Research
24. The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis
    Tino Prell, Janin Lautenschläger, Otto Wilhelm Witte, Maria Teresa Carrı̀, Julian Großkreutz · 2012 · European Journal of Neuroscience
25. Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis
    David J. Baker, Daniel J. Blackburn, Marcus Keatinge, Dilraj Singh Sokhi, Paulius Viskaitis, Paul Roy Heath, Laura Ferraiuolo, Janine Kirby, Pamela J. Shaw · 2015 · Frontiers in Cellular Neuroscience
26. Targeting angiogenin in therapy of amyotropic lateral sclerosis
    Hiroko Kishikawa, David Wu, Guo-fu Hu · 2008 · Expert Opinion on Therapeutic Targets
27. Dopamine, vocalization, and astrocytes
    Ariana Z. Turk, Mahsa Lotfi Marchoubeh, Ingrid Fritsch, Gerald A. Maguire, Shahriar SheikhBahaei · 2021 · Brain and Language
28. Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis
    Charlotte Veyrat‐Durebex, Philippe Corcia, Éric Piver, David Devos, Audrey Dangoumau, Flore Gouel, Patrick Vourc’h, Patrick Emond, Frédéric Laumonnier, Lydie Nadal‐Desbarats et al. · 2015 · Molecular Neurobiology
29. Potential Roles of the WNT Signaling Pathway in Amyotrophic Lateral Sclerosis
    Xin Jiang, Yingjun Guan, Zhenhan Zhao, Fandi Meng, Xuemei Wang, Xueshuai Gao, Jinmeng Liu, Yanchun Chen, Fenghua Zhou, Fenghua Zhou et al. · 2021 · Cells
30. The Role of the Innate Immune System in ALS
    Sudarshan Phani, Diane Bérangère Ré, Serge Przedborski · 2012 · Frontiers in Pharmacology
31. Neuroglial alterations in the zebrafish brain exposed to cadmium chloride
    A. Monaco, M. C. Grimaldi, I. Ferrandino · 2016 · Journal of Applied Toxicology
32. Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose
    Francesca Massenzio, Emiliano Peña‐Altamira, Sabrina Petralla, Marco Virgili, Giampaolo Zuccheri, Andrea Miti, Elisabetta Polazzi, Ilaria Mengoni, Deborah Piffaretti, Barbara Monti · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
33. ALS-Linked SOD1 Mutants Enhance Neurite Outgrowth and Branching in Adult Motor Neurons
    Zachary Osking, Jacob I. Ayers, Ryan P. Hildebrandt, Kristen Skruber, Hilda H. Brown, Daniel H. Ryu, Amanda R. Eukovich, Todd Eliot Golde, David Borchelt, Tracy‐Ann Read et al. · 2018 · iScience
34. Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo
    Georgia Dermentzaki, Kristin A. Politi, Lei Lü, Vartika R. Mishra, Eduardo J. Pérez-Torres, Alexander A. Sosunov, Guy M. McKhann, Francesco Lotti, Neil A. Shneider, Serge Przedborski · 2019 · eNeuro
35. Mitochondria-Targeted Catalase Reverts the Neurotoxicity of hSOD1G93A Astrocytes without Extending the Survival of ALS-Linked Mutant hSOD1 Mice
    Mariana Pehar, Gyda C. Beeson, Craig Cano Beeson, Jeffrey Allan Johnson, Marcelo R. Vargas · 2014 · PLoS ONE
36. Restoration of microglial function by granulocyte-colony stimulating factor in ALS model mice
    Ryo Yamasaki, Masahito Tanaka, Mami Fukunaga, Takahisa Tateishi, Hitoshi Kikuchi, Kyoko Motomura, Takuya Matsushita, Yasumasa Ohyagi, Jun‐ichi Kira · 2010 · Journal of Neuroimmunology
37. Precursor Cell Biology and the Development of Astrocyte Transplantation Therapies: Lessons from Spinal Cord Injury
    Mark Noble, Jeannette E. Davies, Margot Mayer-Pröschel, Christoph Pröschel, Stephen J. A. Davies · 2011 · Neurotherapeutics
38. ALS: Focus on purinergic signalling
    Cinzia Volonté, Savina Apolloni, Maria Teresa Carrı̀, Nadia D’Ambrosi · 2011 · Pharmacology & Therapeutics
39. Stem cell biology and drug discovery
    Lee L. Rubin, Kelly M. Haston · 2011 · BMC Biology
40. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
    Nadia D’Ambrosi, Mauro Cozzolino, Maria Teresa Carrı̀ · 2017 · Antioxidants and Redox Signaling
41. FUS/TLS-immunoreactive Neuronal and Glial Cell Inclusions Increase With Disease Duration in Familial Amyotrophic Lateral Sclerosis With an R521CFUS/TLSMutation
    Naoki Suzuki, Shinsuke Kato, Masako Kato, Hitoshi Warita, Hideki Mizuno, Masaaki Kato, Naoko Shimakura, Haruhiko Akiyama, Zen Kobayashi, Hidehiko Konno et al. · 2012 · Journal of Neuropathology & Experimental Neurology
42. Neuronal polyunsaturated fatty acids are protective in ALS/FTD
    Ashling Giblin, Alexander J. Cammack, Niek Blomberg, Sharifah Anoar, Alla Mikheenko, Mireia Carcolé, Magda Luciana Atilano, Alexander J. Hull, Dunxin Shen, Xiao‐Ya Wei et al. · 2025 · Nature Neuroscience
43. What can pluripotent stem cells teach us about neurodegenerative diseases?
    Hynek Wichterle, Serge Przedborski · 2010 · Nature Neuroscience
44. Adult stem cell therapies for neurological disorders: Benefits beyond neuronal replacement?
    Cédric Boucherie, Emmanuel Hermans · 2008 · Journal of Neuroscience Research
45. Impaired DNA Damage Repair as a Common Feature of Neurodegenerative Diseases and Psychiatric Disorders
    Hiroki Shiwaku, Hitoshi Okazawa · 2015 · Current Molecular Medicine
46. The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability
    Pablo Rozas, Leslie Bargsted, Francisca Martínez, Claudio A. Hetz, Danilo B. Medinas · 2016 · Neuroscience Letters
47. Mutant UBQLN2P497H in motor neurons leads to ALS-like phenotypes and defective autophagy in rats
    Tianhong Chen, Bo Huang, Xinglong Shi, Limo Gao, Cao Huang · 2018 · Acta Neuropathologica Communications
48. Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS
    Francesca Provenzano, Sophie Nyberg, Debora Giunti, Carola Torazza, Benedetta Parodi, Tiziana Bonifacino, Cesare Usai, Nicole Kerlero de Rosbo, Marco Milanese, Antonio Uccelli et al. · 2022 · Cells
49. Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms
    Manling Xie, Praveen N. Pallegar, Sebastian Parusel, Aivi T. Nguyen, Long‐Jun Wu · 2023 · Molecular Neurodegeneration
50. Lack of TNF‐alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression
    Massimo Tortarolo, Antonio Vallarola, Dario Lidonnici, Elisa Battaglia, Francesco Gensano, Gabriella Spaltro, Fabio Fiordaliso, Alessandro Corbelli, Stefano Garetto, Elisa Martini et al. · 2015 · Journal of Neurochemistry
51. Neuron–glia interactions underlie ALS-like axonal cytoskeletal pathology
    Anna Elizabeth King, Tracey C. Dickson, Catherine A. Blizzard, Adele Woodhouse, SS Foster, Roger S. Chung, James Clement Vickers · 2009 · Neurobiology of Aging
52. Patient-Specific Pluripotent Stem Cells in Neurological Diseases
    Serpen Durnaoglu, Şermin Genç, Kürşad Genç · 2011 · Stem Cells International
53. Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
    Naoki Suzuki, Tetsuya Akiyama, Hitoshi Warita, Masashi Aoki · 2020 · Frontiers in Neuroscience
54. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases
    Natalie L. Payne, Aude Sylvain, Carmel O’Brien, Daniella Herszfeld, Guizhi Sun, Claude C.A. Bernard · 2014 · New Biotechnology
55. 14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax
    Sunny R. Slone, Mathieu J. Lesort, Talene A. Yacoubian · 2011 · PLoS ONE
56. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis
    Guanrong Huang, X Lee, Yuting Bian, Zhaohui Shao, G.-N. Sheng, R. Blake Pepinsky, Sha Mi · 2013 · Cell Death and Disease
57. Making the Brain Glow: In Vivo Bioluminescence Imaging to Study Neurodegeneration
    Katja Hochgräfe, Eva‐Maria Mandelkow · 2012 · Molecular Neurobiology
58. Astrocytes conspire with neurons during progression of neurological disease
    James C. McGann, Daniel T. Lioy, Gail Mandel · 2012 · Current Opinion in Neurobiology
59. Stem Cells in the Nervous System
    Angel R. Maldonado‐Soto, Derek H. Oakley, Hynek Wichterle, Joel M. Stein, Fiona K. Doetsch, Christopher E. Henderson · 2014 · American Journal of Physical Medicine & Rehabilitation
60. Management and therapeutic perspectives in amyotrophic lateral sclerosis
    Stéphane Mathis, Philippe Couratier, Adrien Julian, Jean‐Michel Vallat, Philippe Corcia, Gwendal Le Masson · 2016 · Expert Review of Neurotherapeutics
61. Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of ALS
    Lauren Taylor Rosenblum, Shashirekha S. Markandaiah, Biswarup Ghosh, Emily Foran, Angelo C. Lepore, Piera Pasinelli, Davide Trotti · 2017 · Experimental Neurology
62. Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis
    Andrea Serio, Rickie Patani · 2017 · Stem Cells
63. Mitochondrial Transport and Turnover in the Pathogenesis of Amyotrophic Lateral Sclerosis
    Veronica Granatiero, Giovanni Manfredi · 2019 · Biology
64. The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis
    Di He, Yan Chun Xu, Mingsheng Liu, Liying Cui · 2023 · Aging and Disease
65. A Human‐Based Functional NMJ System for Personalized ALS Modeling and Drug Testing
    Xiufang Guo, Virginia Smith, Max Jackson, My Tran, Michael Thomas, Aakash Patel, Eric LoRusso, Siddharth Nimbalkar, Yunqing Cai, Christopher W. McAleer et al. · 2020 · Advanced Therapeutics
66. Intrathecal infusion of a Ca2+-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS
    Hong Zhen Yin, Darryl T. Tang, John H. Weiss · 2007 · Experimental Neurology
67. GFAP‐independent inflammatory competence and trophic functions of astrocytes generated from murine embryonic stem cells
    Philipp B. Kuegler, Bettina Baumann, Bastian Zimmer, Sascha Keller, Andreas Marx, Suzanne Kadereit, Marcel Leist · 2011 · Glia
68. Profiling the genes affected by pathogenic TDP ‐43 in astrocytes
    Cao Huang, Bo Huang, Fangfang Bi, Linda H. Yan, Jianbin Tong, Jufang Huang, Xu‐Gang Xia, Hongxia Zhou · 2014 · Journal of Neurochemistry
69. In the Newborn Hippocampus, Neurotrophin-Dependent Survival Requires Spontaneous Activity and Integrin Signaling
    Sachiko Murase, David F. Owens, Ronald D.G. McKay · 2011 · Journal of Neuroscience
70. Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice.
    Xiaojin Li, Yingjun Guan, Yanchun Chen, Cai‐Xia Zhang, Caixing Shi, Fenghua Zhou, Li Yu, Juan Juan, Xin Wang · 2013 · Europe PMC (PubMed Central)
71. DJ‐1 forms complexes with mutant SOD1 and ameliorates its toxicity
    Satoshi Yamashita, Akira S. Mori, En Kimura, Shuji Mita, Yasushi Maeda, Teruyuki Hirano, Makoto Uchino · 2010 · Journal of Neurochemistry
72. Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation
    Liudmila V. Efremova, Petra Chovancova, Martina Adam, Simon Gutbier, Stefan Schildknecht, Marcel Leist · 2016 · Archives of Toxicology
73. The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93A Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes
    Alessia Serrano, Claudia Donno, Stefano Giannetti, Mina Perić, Pavle R. Anđjus, Nadia D’Ambrosi, Fabrizio Michetti · 2017 · Mediators of Inflammation
74. Mitochondrial Modulation by Dichloroacetate Reduces Toxicity of Aberrant Glial Cells and Gliosis in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis
    Laura Martínez Palma, Ernesto Miquel, Valentina Lagos-Rodríguez, Luis Barbeito, Adriana Cassina, Patricia Cassina · 2018 · Neurotherapeutics
75. Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1G93A mice
    Julia M. Harrison, Victor F. Rafuse · 2020 · Neurobiology of Disease
76. Neuromuscular Development and Disease: Learning From in vitro and in vivo Models
    Zachary Fralish, Ethan M. Lotz, Taylor Chavez, Alastair Khodabukus, Nenad Bursac · 2021 · Frontiers in Cell and Developmental Biology
77. Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis
    Maruša Barbo, Metka Ravnik‐Glavač · 2023 · Genes
78. Astrocytes: The Stars in Neurodegeneration?
    Katarina Stoklund Dittlau, Kristine Freude · 2024 · Biomolecules
79. Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a
    Carlos González‐Fernández, Pau González, Pol Andrés‐Benito, Isidró Ferrer, Francisco Javier Rodríguez · 2019 · Molecular Neurobiology
80. iPSC-based drug screening for Huntington׳s disease
    Ningzhe Zhang, Barbara J. Bailus, Karen L. Ring, Lisa Ellerby · 2015 · Brain Research
81. Astrocytes in Neurodegeneration: Inspiration From Genetics
    Jingxuan Huang, Chunyu Li, Huifang Shang · 2022 · Frontiers in Neuroscience
82. Hu Antigen R (HuR) Is a Positive Regulator of the RNA-binding Proteins TDP-43 and FUS/TLS
    Liang Lu, Lei Zheng, Ying Si, Wenyi Luo, Gwendal Dujardin, Thaddaeus Kwan, Nicholas R. Potochick, Sunnie R. Thompson, David Alan Schneider, Peter H. King · 2014 · Journal of Biological Chemistry
83. Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis
    Felix Benninger, Micaela Johanna Glat, Daniel Offen, Israel Steiner · 2015 · Journal of Clinical Neuroscience
84. Glia–neuron interactions in neurological diseases: Testing non-cell autonomy in a dish
    Kathrin Meyer, Brian K. Kaspar · 2016 · Brain Research
85. SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons
    Teresa N. Patitucci, Allison D. Ebert · 2015 · Human Molecular Genetics
86. Expression profile of pattern recognition receptors in skeletal muscle of SOD1 (G93A) amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients
    Swen Lehmann, E. Esch, P. Hartmann, Anand Goswami, Stefan Nikolin, Joachim Weis, Cordian Beyer, Sonja Johann · 2018 · Neuropathology and Applied Neurobiology
87. Matrix metalloproteinase-9 regulates neuronal circuit development and excitability
    Murase, Sachiko, Lantz, Crystal L., Kim, Eunyoung, Gupta, Nitin, Higgins, Richard, Stopfer, Mark, Hoffman, Dax A., Quinlan, Elizabeth M. · 2016 · Molecular Neurobiology
88. Mutant HSPB1 overexpression in neurons is sufficient to cause age-related motor neuronopathy in mice
    Amit K. Srivastava, Samantha R. Renusch, Nicole E. Naiman, Shuping Gu, Amita Sneh, William David Arnold, Zarife Sahenk, Stephen J. Kolb · 2012 · Neurobiology of Disease
89. Altered astrocytic response to activation in SOD1G93A mice and its implications on amyotrophic lateral sclerosis pathogenesis
    Chen Benkler, Tali Ben‐Zur, Yael Barhum, Daniel Offen · 2012 · Glia
90. Genetic validation of a therapeutic target in a mouse model of ALS
    A. Sophie de Boer, Kathryn Koszka, Evangelos Kiskinis, Naoki Suzuki, Brandi N. Davis‐Dusenbery, Kevin C. Eggan · 2014 · Science Translational Medicine
91. Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
    Aurélie de Rus Jacquet, Hélèna L. Denis, Francesca Cicchetti, Melanie Alpaugh · 2021 · Molecular Psychiatry
92. Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis
    Edor Kabashi, Jeffrey N. Agar, Yu H. Hong, David M. Taylor, Sandra Minotti, Denise A. Figlewicz, Heather D. Durham · 2008 · Journal of Neurochemistry
93. Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine
    Praveen Paul, Tytus Murphy, Zainab Oseni, Suganthinie Velagala, Jacqueline de Belleroche · 2013 · Neurobiology of Aging
94. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice
    Kazunori Tanaka, Yoshinori Okada, Takuya Kanno, Asako Otomo, Yoshiko Yanagisawa, Junko Showguchi-Miyata, Etsuko Suga, Eri Kohiki, Kyuichiro Onoe, Hitoshi Osuga et al. · 2008 · Experimental Neurology
95. Retrograde labeling, transduction, and genetic targeting allow cellular analysis of corticospinal motor neurons: implications in health and disease
    Javier H. Jara, Genc Baris, Jodi L. Klessner, P. Hande Özdi̇nler · 2014 · Frontiers in Neuroanatomy
96. Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis
    Chrissandra J. Zagami, Philip M. Beart, Nicole Wallis, Phillip Nagley, Ross D. O’Shea · 2008 · Glia
97. Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis
    Brambilla, Liliana, Martorana, Francesca, Guidotti, Giulia, Rossi, Daniela · 2018 · Frontiers in Neuroscience
98. The regulation of the small heat shock protein B8 in misfolding protein diseases causing motoneuronal and muscle cell death
    Cristofani, Riccardo, Rusmini, Paola, Galbiati, Mariarita, Cicardi, Maria Elena, Ferrari, Veronica, Tedesco, Barbara, Casarotto, Elena, Chierichetti, Marta, Messi, Elio, Piccolella, Margherita et al. · 2019 · Frontiers in Neuroscience
99. Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice
    Nur Jury, Sebastián Abarzúa, Iván Darío Parrado Díaz, Miguel V. Guerra, Estíbaliz Ampuero, Paula Cubillos, Pablo Martínez, Andrea Herrera-Soto, Cristián Arredondo, Fabiola Rojas et al. · 2020 · Clinical Epigenetics
100. Efficient and rapid conversion of human astrocytes and ALS mouse model spinal cord astrocytes into motor neuron-like cells by defined small molecules
     Andong Zhao, Hua Qin, Mengli Sun, Kui Ma, Xiaobing Fu · 2020 · Military Medical Research